# Hyaluronic Acid Joint Comfort Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/hyaluronic-acid-joint-comfort-meta-analysis-evidence-review
Category: evidence-review
Summary: Hyaluronic Acid Joint Comfort Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass
Last reviewed: 2026-07-29
Reviewed by: Migaku Evidence Review
# Hyaluronic Acid Joint Comfort Meta-analysis: What the Evidence Says

## Quick Answer

Hyaluronic Acid Joint Comfort Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are guideline, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 guideline, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Expert consensus on hyaluronic acid injections for knee osteoarthritis: a patient-centered approach | guideline | 2 | 2026-04-01 | 10.1007/s40520-026-03366-8 |
| Current Non-operative Management of Shoulder Pathologies: A Narrative Review | preclinical study | 4 | 2025-12-05 | 10.7759/cureus.98500 |

## What The Sources Report

- The purpose of this working group was to consider the latest qualitative and quantitative evidence regarding the use of IAHA in the treatment of knee OA. [Fuggle Nicholas (2026); evidence level 2]
- The concept of a ‘window of opportunity' is associated with a desire to identify individuals in pre-disease, or in an early stage of disease, when non-surgical intervention has the ability to change the course of a condition and, potentially, even reverse a disease trajectory. [Fuggle Nicholas (2026); evidence level 2]
- Lifetime prevalence of shoulder pain approaches 70%, with monthly prevalence estimates of 18-31% in the general population; the burden rises with age and is associated with disability, sleep disruption, productivity loss, and substantial healthcare utilization. [Muacevic Alexander (2025); evidence level 4]
- The novelty of this review lies in consolidating contemporary evidence and guideline-informed recommendations across all major shoulder pathologies into a single, clinically focused synthesis to support everyday orthopaedic and sports medicine decision-making. [Muacevic Alexander (2025); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For hyaluronic acid joint comfort meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Fuggle Nicholas (2026). Expert consensus on hyaluronic acid injections for knee osteoarthritis: a patient-centered approach. DOI: 10.1007/s40520-026-03366-8. PMCID: PMC13061766. PMID: 41920453. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13061766/
- Muacevic Alexander (2025). Current Non-operative Management of Shoulder Pathologies: A Narrative Review. DOI: 10.7759/cureus.98500. PMCID: PMC12765153. PMID: 41492609. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12765153/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.